SBIR/STTR Research Award
Recovery Housing for Medication Assisted Treatment - Stepping Stones
Award amount
$190,357Program and phase
SBIR · Phase IAward year
2018Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Stepping Stones
- Proposal award date
- 2018-05-01
- Contract end date
- 2019-03-31
- UEI
- GH8CFK1CQZM6
- Solicitation number
- PA17-302
- Topic code
- NIDA
Research abstract
PROJECT SUMMARY ABSTRACT
Stepping Stones proposes to implement a recovery housing model customized for thepersons enrolled in Medication Assisted Treatment programs in the United StatesStepping Stones
will increase MAT participation and retentionrecovery self efficacyemploymentand incomePhasewill demonstrate feasibility using a sample of females with opioid use disorders who are enrolled in
MAT PROJECT NARRATIVE
Opioid abuse is epidemic in the United States and effective interventions are needed to promote adherence
with evidence based treatment modalitiesMost recovery based housinge gsober livinghalf way housesOxford Housesdiscriminates against persons enrolled in the most effective treatment for opioid addictionMedication Assisted TreatmentThis project will develop a MAT friendly housing model that demonstrates long
terms outcomes
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)